Reduced postmortem activity of cPLA2 and iPLA2 was reported in parietal and temporal cortices of AD subjects, as well as cPLA2 activity in the hippocampus (65, 84, 85). This evidence concerns the gene PLA2G6 and Alzheimer disease.